We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Biocartis Spins Out Life Sciences Multiplex Platform Evalution into Mycartis

News   Sep 06, 2014

 
Biocartis Spins Out Life Sciences Multiplex Platform Evalution into Mycartis
 
 
Advertisement
 

RELATED ARTICLES

A Step Closer to A Blood Test for Diagnosing Mood Disorders?

News

A new study published in Molecular Psychiatry outlines the development of an RNA biomarker-based blood test for distinguishing how severe an individual's depression is, determining the risk of a patient developing severe depression in the future, determining the risk of future bipolar disorder and tailored medication choices for patients.

READ MORE

Breath Test Developed for Methylmalonic Acidemia

News

Researchers at the National Institutes of Health have developed a breath test that measures how well patients with methylmalonic acidemia (MMA) respond to receiving liver or combined liver and kidney transplantation. Researchers also used the test to assess the severity of the disease in people and help determine if they would benefit from surgical or experimental genomic therapies that target the liver.

READ MORE

Nanoparticle “Tattoo” Changes Color in Response to Drug Concentration in the Blood

News

Scientists have developed a novel type of implantable sensor that can be embedded into an artificial polymeric tissue. The sensor is based on color-stable gold nanoparticles that are modified with receptors for specific molecules. The nanogold is implanted under the skin where it reports changes in drug concentrations by changing its color.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE